Health Care/Hospital

Ping An Reports 1H 2026 Results

Operating Profit[1] Grows 8.3% YoY; Net Profit[2] Surges 36.1% YoY; Interim Dividend Increases 3.2% YoY HONG KONG and SHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group", HKEX: 2318; SSE: 601318) today announced its 2026 interim res...

2026-08-20 19:36 180

ISoOR 2026 Organoid Clinical Transformation Summit convened in Hangzhou

ICORE launched; nine companies joined as founding members HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ -- On August 18, the International Society of Organoid Research (ISoOR) held its 2026 Organoid Clinical TransformationSummit in Hangzhou. Under the theme "From Biological Models to Credible Evid...

2026-08-20 13:08 384

Australian-first roadmap calls for national reform to protect people and pets from family violence

Led by Lucy's Project and supported by the Petstock Foundation, the National Roadmap for Change aims to ensure victim-survivors can seek safety without leaving their pets behind CANBERRA, Australia, Aug. 20, 2026 /PRNewswire/ -- A new National Roadmap for Change to Prevent and End Family Violenc...

2026-08-20 09:40 403

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance[1]: Double-digit revenue growth and gross margin imp...

2026-08-20 08:02 776

Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer

oncoReveal® Essential+ validated at LSI Medience for cfDNA/cfRNA screening in the LC-SCRUM-Asia project, with testing planned to begin in August 2026 NATICK, Mass. and TOKYO, Aug. 20, 2026 /PRNewswire/ -- Pillar Biosciences, Inc. ("Pillar"), LC-SCRUM-Asia and LSI Medience Corporation ("LSI Medie...

2026-08-20 06:00 950

Dubai Police Initiatives Drive $176.4 Million in Social Value and Gains in Safety, Wellbeing and the Economy, Study Reveals

DUBAI, UAE, Aug. 19, 2026 /PRNewswire/ -- A study has estimated the Social Return on Investment (SROI) of 80Dubai Police  community initiatives at AED 647.9 million ($176.4 million), reflecting the wider social, economic and security value created for 3.8 million b...

2026-08-19 22:12 1299

DrFirst Receives Frost & Sullivan's 2026 North America Enabling Technology Leadership Recognition for Advancing AI-Enhanced Medication Orchestration

DrFirst is honored for redefining medication management with its scalable platform that embeds intelligence directly in prescribing, making it more efficient for providers, pharmacies, and patients. SAN ANTONIO, Aug. 19, 2026 /PRNewswire/ -- As healthcare organizations continue to navigate fragm...

2026-08-19 21:00 1258

ZEISS CLINIC 360 receives FDA 510k clearance, amplifying patient care through simplified clinical insights

The ZEISS CLINIC 360 all-in-one browser-based software solution aggregates clinical data at scale and powers advanced analytics for streamlined ophthalmic workflows, providing clinicians with more time for personalizing patient care. JENA, Germany, Aug. 19, 2026 /PRNewswire/ -- ZEISS Medical Tech...

2026-08-19 21:00 1271

Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion

HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Sino Biopharmaceutical Limited (HKEX: 01177), a leading innovation-driven pharmaceutical company in China, announced the launch of its new global brand, SBP Group, during its interim results meeting. SBP stands for Science, Breakthroughs and Patients: Scie...

2026-08-19 19:45 1238

Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care

Patients from Australia, India, Indonesia, South Korea and Singapore gathered at Edwards Lifesciences' annual APAC Patient Experience event to share their stories and help advance more patient-centered care. SINGAPORE, Aug. 19, 2026 /PRNewswire/ -- As structural heart disease continues to impact...

2026-08-19 17:11 782

MALAYSIA AND BANGLADESH TRANSLATE LEADERS' COMMITMENT INTO HEALTHCARE COOPERATION

Health Ministry Seeks Affordable Malaysian Healthcare for Bangladeshi Patients DHAKA, Bangladesh, Aug. 19, 2026 /PRNewswire/ -- A delegation from Malaysia Healthcare Travel Council (MHTC), led by H.E. Mohd Shuhada Othman, High Commissioner of Malaysia to Bangladesh, met with H.E. Sardar Md. Sakha...

2026-08-19 16:43 651

Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026

VALBY, Denmark, Aug. 19, 2026 /PRNewswire/ -- Key highlights Lundbeck's total revenue grew by +16% CER[1] (+11% DKK) to DKK 13,588 million in the first six months of 2026, with the U.S. and Europe delivering double-digit growth. The performance reflected continued strong commercial momentum, dr...

2026-08-19 14:48 503

Everest Medicines Announces Interim Results for First Half of 2026

SHANGHAI, Aug. 19, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced its interim results for the first hal...

2026-08-19 11:39 892

Hi & Fi Asia-China 2026 Concludes in Shanghai with Record Numbers, Handing the Baton to Hi & Fi Shenzhen This Autumn

Connecting Global Health & Food Ingredient Suppliers with Greater Bay Area Opportunities from 13–15 October 2026 at Shenzhen World SHANGHAI, Aug. 19, 2026 /PRNewswire/ -- The 27th Hi & Fi Asia-China 2026 concluded successfully in Shanghai in June, setting historic records. Centered on the theme ...

2026-08-19 10:00 817

GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma

* Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 * Blenrep, a first-in-class anti-BCMA ADC, could transform treatment as early as first relapse where additional effective treatment options are needed [...

2026-08-19 10:00 786

Ping An Good Doctor Announces 2026 Interim Results

Corporate Health Management Business Grows Steadily; AI Healthcare Empowerment Drives Continued Profitability Improvement HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its interim ...

2026-08-19 09:09 1046

Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit

SHANGHAI and HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-08-19 09:00 625

GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue PISCATAWAY, N.J., Aug. 18, 2026 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548) reported first-half revenue of approximately US$404.2 million on a comparable basis, up 27....

2026-08-18 22:15 1711

Frost & Sullivan: Juno Health Receives the 2026 North American Modular EHR Delivery Customer Value Leadership Recognition for Excellence in Cloud-Native EHR Innovation

The company stands out for delivering a scalable, cloud-native platform that enhances customer experience through flexible system ownership, operational efficiency, and cost-effective EHR modernization. SAN ANTONIO, Aug. 18, 2026 /PRNewswire/ -- This week we would like to congratulateJuno Health...

2026-08-18 21:00 969

Fractal Wins US$17M+ Multi-Year AI Deal with a Fortune 500® U.S. Healthcare Organization

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Fractal Analytics Ltd.  (BSE: 544700) (NSE: FRACTAL), a globally recognized enterprise AI company serving Fortune 500® organizations, announced that it has secured a US$17M+ multi-year agreement with a leading U.S. healthcare enterp...

2026-08-18 17:44 752
12345 ... 531